Ned Scheetz is the General Partner and founder of Aphelion Capital.  For over two decades, Mr. Scheetz has been an investor in numerous public and private healthcare companies.  Mr. Scheetz was a Partner and Managing Director with Piper Jaffray Ventures and a Senior Analyst with Janus Capital.  Prior to beginning his investment career, Mr. Scheetz held a number of sales and marketing positions with divisions of Eastman Kodak and Kraft General Foods.  Mr. Scheetz has served on a wide variety of corporate and non-profit boards in his career.

Mr. Scheetz is an advisory board member with the Center for Medical Device Innovation, and on the business advisory board of The Epilepsy Therapy Development Project.  A graduate of Duke University’s Fuqua School of Business, Colby College, and a post-graduate scholar at Oxford University, Mr. Scheetz also holds the CFA designation.